Celgene Corp (NASDAQ:CELG)

Delayed Data
As of Mar 03
 -1.84 / -1.53%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 24 analysts offering 12-month price forecasts for Celgene have a median target of 140.00, with a high estimate of 163.00 and a low estimate of 74.00. The median estimate represents a +18.17% increase from the last price of 118.47.

Analyst Recommendations

The current consensus among 29 polled investment analysts is to Buy stock in Celgene. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.51%
Growthannually 30.02%


Growthquarterly 1.65%
Growthannually 21.43%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account